Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,178
Total Claims
$1.0M
Drug Cost
652
Beneficiaries
$1,596
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+8%
Opioid rate vs peers
2.7% vs 2.5% avg
+41%
Cost per patient vs peers
$1,596 vs $1,128 avg
+19%
Brand preference vs peers
10.0% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
2.7%
Opioid Rate
380
Opioid Claims
$14K
Opioid Cost
10.8%
Long-Acting Rate
Brand vs Generic
Brand: 1,414 claims · $719K
Generic: 12,689 claims · $316K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 264 | $194K |
| Semaglutide | 51 | $57K |
| Sitagliptin Phosphate | 84 | $54K |
| Insulin Detemir | 52 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 79 | $40K |
| Rivaroxaban | 31 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $23K |
| Insulin Aspart | 24 | $23K |
| Gabapentin | 12 | $19K |
| Metoprolol Succinate | 604 | $18K |
| Rosuvastatin Calcium | 781 | $18K |
| Budesonide/Formoterol Fumarate | 44 | $18K |
| Tirzepatide | 15 | $17K |
| Semaglutide | 13 | $16K |
| Estradiol | 301 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
0.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About